ASH Action Center
Welcome to the ASH Action Center, bringing you the latest updates from the annual American Society of Hematology (ASH) Meeting and Exposition. This collection features expert and scientific insights from the conference that highlight key strategies and research on the hottest topics in hematology.
Evaluating a Lower-Intensity Treatment Regimen in AML: Phase 2 Results from PARADIGM
Project Oncology®Evaluating a Lower-Intensity Treatment Regimen in AML: Phase 2 Results from PARADIGM
Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Project Oncology®Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Relapsed or Refractory DLBCL: Reviewing the Expanding Treatment Landscape
Project Oncology®Relapsed or Refractory DLBCL: Reviewing the Expanding Treatment Landscape
Treating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches
Project Oncology®Treating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches
Understanding Heparin Resistance: Underlying Mechanisms and Alternative Treatment Options
Project Oncology®Understanding Heparin Resistance: Underlying Mechanisms and Alternative Treatment Options
- advertisement
- 12/01/2025
- 11/28/2025
- 11/27/2025